264
Views
6
CrossRef citations to date
0
Altmetric
Clincial

Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis

, ORCID Icon, , ORCID Icon, , , & ORCID Icon show all
Pages 388-394 | Received 14 Sep 2020, Accepted 31 Jan 2021, Published online: 01 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rubika Balendra, Ashley R. Jones, Ahmad Al Khleifat, Theresa Chiwera, Paul Wicks, Carolyn A. Young, Pamela J. Shaw, Martin R. Turner, P. Nigel Leigh & Ammar Al-Chalabi. (2023) Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 71-81.
Read now

Articles from other publishers (5)

Jiaqian Li, Fangyu Dai, Xuelian Kou, Bin Wu, Jie Xu & Songbin He. (2022) β-Actin: An Emerging Biomarker in Ischemic Stroke. Cellular and Molecular Neurobiology 43:2, pages 683-696.
Crossref
Xiaoxiao Xing, Qingyu lv, Chunyu Sun, Jia Song, Zhixin Chen, Yong Jiang, Ye Wang, Yongqiang Jiang & Zhifei Wang. (2023) One-step preparation of PEG segment-functionalized polystyrene microspheres and their application as latex in LOCI. New Journal of Chemistry 47:8, pages 3970-3977.
Crossref
Ali Aamir, Hussain Haider Shah & Tehreem Mansure. (2022) “Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis”. European Journal of Neurology 30:1, pages 285-286.
Crossref
Shifu Li, Qian Zhang, Jian Li & Ling Weng. (2022) Comprehensive analysis of autoimmune-related genes in amyotrophic lateral sclerosis from the perspective of 3P medicine. EPMA Journal 13:4, pages 699-723.
Crossref
Masaaki Ito, Takaki Hiwasa, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Shu-Yang Li, Yasuo Iwadate, Kazuo Sugimoto, Masahiro Mori, Satoshi Kuwabara, Hirotaka Takizawa & Hideaki Shimada. (2022) Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma. Esophagus 19:4, pages 617-625.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.